Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJPMorgan European Discovery Trust Regulatory News (JEDT)

Share Price Information for JPMorgan European Discovery Trust (JEDT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 483.00
Bid: 482.00
Ask: 483.50
Change: 3.00 (0.63%)
Spread: 1.50 (0.311%)
Open: 480.00
High: 483.50
Low: 480.00
Prev. Close: 480.00
JEDT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

13 Dec 2022 07:59

RNS Number : 5158J
JPMorgan European Discovery Trust
13 December 2022
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMorgan European DISCOVERY Trust plc

 

Half Year Report & FINANCIAL STATEMENTS for the six months

ended 30TH September 2022

 

Legal Entity Identifier: 54930049CEWDI46Y3U28

Information disclosed in accordance with DTR 4.2.2

 

CHAIRMAN'S STATEMENT

Dear Shareholder,

I hereby present the Company's results for the half-year ended 30th September 2022. 

Performance

European markets have faced a challenging environment during recent months, dominated by significant geo-political uncertainty and heightened market volatility. Following the Covid-19 pandemic, supply side bottlenecks and consequential rising prices have been further stressed by the tragic events following Russia's invasion of Ukraine. Food supplies and energy needs affected by the disruption have become key concerns. It has had a material adverse short-term impact on the value of our portfolio. However, the longer-term performance of our portfolio remains strong.

During the half year to 30th September 2022, the Company recorded a total return on net assets of -18.1%, with the Company's benchmark index, the MSCI Europe (ex UK) Small Cap Index, returning -19.3% over the same period. The total return to shareholders was -19.8%, reflecting a slight widening of the discount at which the Company's shares trade from 14.4% to 16.5% over the six months.

The Company's longer term performance with the 5 year and 10 year total return on net assets was 3.9% and 202.7%, respectively, whilst the benchmark total return was 9.1% and 171.4%. The Investment Managers' Report that follows provides a review of markets, more detail on the performance drivers within the portfolio and the outlook for investing.

Revenue and Dividends

Net revenue return for the six months to 30th September 2022 was higher than the corresponding period in 2021 at 10.43 pence per share (2021: 6.57 pence). The Board has decided to maintain the interim dividend of 1.2 pence (2021: 1.2 pence) per share which will be paid on 3rd February 2023 to shareholders on the register as at 23rd December 2022 (the ex-dividend date will be 22nd December 2022). The Board will keep this under review and take into account the income received and the level of the Company's revenue reserves when determining the final dividend for the year in 2023.

Discount Management and Share Repurchases

The Board continues to monitor closely the level of the discount and considers its ability to repurchase shares to minimise the short term volatility and the absolute level of the discount of prime importance. 995,000 shares were repurchased in the six months to 30th September 2022. No shares have been repurchased since the period end.

The Board

In line with the Board's succession planning, the intention had been for Ashok Gupta to stand down at this year's AGM, having served on the Board for nine years. However, in light of some of the recent changes in the Board composition, the Board agreed that it would be appropriate for the Company to continue to benefit from Ashok's extensive industry experience for a further few months.

No changes were made to the Board in the reporting period.

 

Environmental, Social and Governance ('ESG')

As highlighted in the 2022 Annual Report, the Board has continued to engage with the Manager on the integration of ESG factors into its investment process. While the investment managers have always considered environmental, social and governance ('ESG') issues in their investment process, it is now rigorously integrated into their investment processes so that ESG issues are considered at every stage of the investment decision. For more details, please refer to pages 21 to 23 of the 2022 Annual Report which can be found on the Company's website at: www.jpmeuropeandiscovery.co.uk

Outlook

Geopolitical tensions, elevated market volatility, and the fastest pace of central bank tightening in decades are meaningful economic headwinds contributing to an unusually uncertain environment at the moment. In Europe, inflation is being acutely felt as the Russia-Ukraine conflict has pushed gas prices to new highs, triggering a cost of living crisis. It seems probable that equity markets will continue to struggle until higher interest rates appear to be working and bringing inflation under control. Nonetheless, European equities continue to trade at a discount to global peers, providing attractive investment opportunities for our Portfolio Managers. It is likely that the macroeconomic

environment may remain uncertain over the coming months, however, the Portfolio Managers' approach to dealing with an uncertain economic and geo-political environment should continue to serve shareholders well.

 

Marc van Gelder Chairman

 

INVESTMENT MANAGERS' REPORT

Review

Equity market weakness continued in the six months to September 2022 as inflationary pressures remained high. Several factors contributed to inflation including the Russian invasion of Ukraine, continued supply chain disruptions exacerbated by China's Zero-Covid policy, and a normalisation of demand post Covid-19 related lockdowns.

The benchmark MSCI Europe (ex UK) Small Cap NR Index fell by 19.3 per cent, underperforming the large cap MSCI Europe (ex UK) NR Index which fell 10.5 per cent.

Portfolio

The NAV of the portfolio decreased by 18.1 per cent over the period, outperforming its benchmark by 1.2 per cent.

Contributors to performance included the French market research company, Ipsos, after the company continued to report a very strong order backlog as high global macroeconomic uncertainty resulted in high demand for customer insights. The Company also continued to benefit from its strong tilt towards the sustainability theme. Investments in the European cable manufacturers, Pysmian, Nexans and NKT (Italian, French and Danish listed), continued to outperform supported by very high demand for electrification. French Engineering company, Spie, also fits into this category as it is focused in rolling out the practical solutions required to electrify infrastructure.

As in the previous period, detractors from performance were predominantly past 'high quality growth' winners that continued to see significant multiple contraction due to rising bond yields. Underperformers include Belgian warehousing companies, Warehouses De Pauw and VGP. The German forklift truck manufacturer, Kion, detracted from performance as it was unable to pass on cost inflation in a number of its long term projects. Inflation has also weighed on consumer demand which has been a headwind for companies such as Danish audio solutions manufacturer, GN Store Nord and French animal pharmaceutical company, Virbac.

During the period we took advantage of significant valuation deratings to purchase a number of attractive high quality companies which now trade on significantly lower valuations. These included Italian diagnostics company, DiaSorin, Italian pure play renewables company, ERG, whose high exposure to spot power prices directly benefited the company given the European energy situation, and Finnish consumer packaging producer, Huhtamaki, whose margins are likely to benefit from falling raw material prices and continued strong demand for their sustainable solutions.

To fund these purchases sold out of several companies which are likely to be impacted by the current uncertain macroeconomic environment and high energy prices. These include industrial companies Indutrade, Pirelli, Rexel, and Belimo.

Communication Services rose to become the largest sector overweight. This shift was a result of the outperformance of Ipsos, the French market research company mentioned above, and a reduction in the Industrials overweight. This reduction was a result of the sale of several of the Company's more macroeconomically exposed investments such as the Dutch manufacturer of energy-efficient lighting solutions, Signify, and Italian premium tyre manufacturer, Pirelli. Financials and Energy were the largest underweights.

France and Italy remained the two largest country overweights, while Norway and Germany remained the two largest underweights.

At the end of September, the net cash was -4.16%.

Outlook

We started the year believing (like many market participants) that inflation would prove to be transitory. The sad events in the Ukraine and more recently the lockdowns in China make it highly unlikely that the high levels we are currently seeing will quickly revert to Central Bank targets. The positive aspect of equities, unlike bonds, is that there are companies and sectors that can still perform in inflationary environments and those are the companies which we have been increasingly investing in. For instance, companies with high barriers to entry and pricing power should be able to pass on inflation. Certain areas of insurance combine a positive exposure to rising bond yields and defensive business models. Companies who see demand greatly exceeding their potential to supply, such as the high voltage cable manufacturers, or those companies exposed to the electrification theme, should also find themselves well placed to raise their prices.

 

While it is difficult to predict when the current inflationary environment will end, historically European smaller companies have been one of the best performing asset classes globally, and we do not see the fundamentals that drove this changing. Innovation has powered smaller companies and will continue to do so long into the future. As always it is our job to uncover these opportunities.

 

Francesco ConteEdward Greaves Investment Managers

 

 

 

 

 

 

 

 

 

INTERIM MANAGEMENT REPORT

The Company is required to make the following disclosures in its half year report:

Principal Risks and Uncertainties

The principal and emerging risks and uncertainties faced by the Company fall into the following broad categories:

investment underperformance and strategy; market and currency; accounting, legal and regulatory; operational;

cyber-crime, financial, corporate governance and shareholder relations, climate change and emerging risks.

The Board has reviewed the principal risks and uncertainties, reported in the Annual Report and Financial Statements for the year ended 31st March 2022, and concluded that the emerging risks identified within that Annual Report in respect of geopolitical and global recession are now principal risks. In the view of the Board, these principal risks and uncertainties are as much applicable to the remaining six months of the financial year as they were to the six months under review.

Related Parties Transactions

During the first six months of the current financial year, no transactions with related parties have taken place which have materially affected the financial position or the performance of the Company.

Going Concern

In accordance with The Financial Reporting Council's guidance on going concern and liquidity risk, including its Covid-19 guidance, the Directors have undertaken a rigorous review of the Company's ability to continue as a going concern. The Board has, in particular, considered the impact of heightened market volatility since the Covid-19 outbreak and more recently the Russian invasion of Ukraine, but does not believe the Company's going concern status is affected. The Company's assets, which are investments in quoted securities which are readily realisable, exceed its liabilities significantly under all stress test scenarios reviewed by the Board. Gearing levels and compliance with borrowing covenants are reviewed by the Board on a regular basis. Furthermore, the Directors are satisfied that the Company and its key third party service providers have in place appropriate business continuity plans. Accordingly, having assessed the principal and emerging risks and other matters, the Directors believe that there are no material uncertainties pertaining to the Company that would prevent its ability to continue in such operational existence for at least 12 months from the date of the approval of this half yearly financial report.

Directors' Responsibilities

The Board of Directors confirm that, to the best of its knowledge:

(i) the condensed set of financial statements contained within the half-yearly financial report has been prepared in accordance with FRS 104 'Interim Financial Reports' and gives a true and fair view of the state of affairs of the Company and of the assets, liabilities, financial position and net return of the Company, as at 30th September 2022, as required by the UK Listing Authority Disclosure Guidance and Transparency Rules 4.2.4R; and

(ii) the interim management report includes a fair review of the information required by 4.2.7R and 4.2.8R of the UK Listing Authority Disclosure Guidance and Transparency Rules.

In order to provide these confirmations, and in preparing these financial statements, the Directors are required to:

· select suitable accounting policies and then apply them consistently;

· make judgements and accounting estimates that are reasonable and prudent;

· state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

· prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business;

and the Directors confirm that they have done so.

 

For and on behalf of the Board Marc van Gelder Chairman

 

STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED 30th SEPTEMBER 2022

(Unaudited)

Six months ended

30th September 2022

(Unaudited)

Six months ended

30th September 2021

(Audited)

Year ended

31st March 2022

 

Revenue£'000

Capital£'000

Total£'000

Revenue£'000

Capital£'000

Total£'000

Revenue£'000

Capital£'000

Total£'000

(Losses)/gains on investments held at fair value through profit or loss

 -

 (164,778)

 (164,778)

 -

 105,756

 105,756

-

 (1,046)

 (1,046)

Foreign exchange gains/(losses) on liquidity fund

 -

 1,819

 1,819

 -

 38

 38

-

(860)

(860)

 

Net foreign currency losses

 -

 (1,455)

 (1,455)

 -

 (1,097)

 (1,097)

-

(253)

(253)

 

Income from investments

 19,359

 -

 19,359

 13,687

 -

 13,687

16,360

-

16,360

 

Interest receivable and similar income

 70

 -

 70

 113

 -

 113

138

-

138

 

Gross return/(loss)

 19,429

 (164,414)

 (144,985)

 13,800

 104,697

 118,497

16,498

 (2,159)

14,339

 

Management fee

 (989)

 (2,308)

 (3,297)

 (1,168)

 (2,725)

 (3,893)

(2,360)

(5,507)

(7,867)

 

Other administrative expenses

 (312)

-

 (312)

 (309)

 -

 (309)

(719)

-

(719)

 

Net return/(loss) before finance costs and taxation

 18,128

 (166,722)

 (148,594)

 12,323

 101,972

 114,295

13,419

(7,666)

5,753

 

Finance costs

 (138)

 (321)

 (459)

 (136)

 (318)

 (454)

(271)

 (633)

(904)

 

Net return/(loss) before taxation

 17,990

 (167,043)

 (149,053)

 12,187

 101,654

113,841

13,148

(8,299)

4,849

 

Taxation

 (1,548)

-

 (1,548)

 (1,716)

 -

 (1,716)

(1,994)

-

(1,994)

 

Net return/(loss) after taxation

 16,442

 (167,043)

 (150,601)

 10,471

 101,654

 112,125

11,154

(8,299)

2,855

 

Return/(loss) per share (note 3)

10.43p

(105.95)p

 (95.52)p

 6.57p

 63.75p

 70.32p

7.00p

(5.21)p

1.79p

 

 

 

 

 

 

STATEMENT OF CHANGES IN EQUITY

FOR THE SIX MONTHS ENDED 30th SEPTEMBER 2022

 

Called upsharecapital£'000

Share

premium

£'000

Capital redemption reserve£'000

Capitalreserves1£'000

Revenue reserve1£'000

Total£'000

Six months ended 30th September 2022(Unaudited)

 

 

 

 

 

At 31st March 2022

7,924

1,312

7,712

805,617

11,154

833,719

Repurchase and cancellation of the Company's own shares

 (50)

-

 50

 (4,254)

-

 (4,254)

Net (loss)/return

-

-

-

 (167,043)

 16,442

 (150,601)

Dividend paid in the period (note 4)

-

-

-

-

 (8,661)

 (8,661)

At 30th September 2022

 7,874

 1,312

 7,762

 634,320

 18,935

 670,203

Six months ended 30th September 2021(Unaudited)

 

 

 

 

 

At 31st March 2021

 7,974

 1,312

 7,662

 820,196

 9,160

 846,304

Net return

-

-

-

 101,654

 10,471

 112,125

Dividend paid in the period (note 4)

-

-

-

-

 (8,770)

 (8,770)

At 30th September 2021

 7,974

 1,312

 7,662

 921,850

 10,861

 949,659

Year ended 31st March 2022 (Audited)

 

 

 

 

 

At 31st March 2021

7,974

1,312

7,662

820,196

9,160

 846,304

Repurchase and cancellation of Company's own shares

(50)

-

50

(4,760)

-

(4,760)

Net (loss)/return on ordinary activities

-

-

-

 (8,299)

 11,154

 2,855

Dividends paid in the year (note 4)

-

-

-

(1,520)

(9,160)

(10,680)

At 31st March 2022

7,924

1,312

7,712

805,617

11,154

833,719

 

1 These reserves form the distributable reserves of the Company and may be used to fund distribution of profits to investors via dividend payments.For the year ended 31st March 2022 the dividend payment was split between revenue reserve and capital reserve as the revenue reserve opening balance was entirely exhausted.

 

 

STATEMENT OF FINANCIAL POSITION

AT 30th SEPTEMBER 2022

 

(Unaudited)

30th September 2022£'000

(Unaudited)

30th September 2021£'000

(Audited)

31st March 2022

£'000

Fixed assets

Investments held at fair value through profit or loss

 642,346

 961,055

834,018

Current assets

Derivative financial instruments

-

 1

2

Debtors

 5,482

 12,400

2,266

Cash and cash equivalents

 57,729

 54,918

75,318

 63,211

 67,319

77,586

Current liabilities

Creditors: amounts falling due within one year

 (35,354)

 (1,339)

(77,885)

Derivative financial liabilities

-

 (18)

-

Net current assets/(liabilities)

 27,857

 65,962

(299)

Total assets less current liabilities

 670,203

 1,027,017

833,719

Creditors: amounts falling due after more than one year

-

 (77,358)

-

Net assets

 670,203

 949,659

833,719

Capital and reserves

 

 

 

Called up share capital

7,874

 7,974

7,924

Share premium

1,312

 1,312

1,312

Capital redemption reserve

7,762

 7,662

7,712

Capital reserves

634,320

 921,850

805,617

Revenue reserve

18,935

 10,861

11,154

Total shareholders' funds

670,203

 949,659

833,719

Net asset value per share (note 5)

425.6p

595.5p

526.1p

 

 

STATEMENT OF CASH FLOWS

FOR THE SIX MONTHS ENDED 30th SEPTEMBER 2022

(Unaudited)Six months ended

30th September 2022£'000

(Unaudited)Six months ended

30th September 2021£'000

(Audited)Year ended

31st March 2022

£'000

Net cash outflow from operations before dividendsand interest (note 6)

 (2,882)

 (4,740)

(10,675)

Dividends received

 16,084

 11,254

13,119

Interest received

 -

 1

 1

Overseas tax recovered

 531

 148

215

Interest paid

 (536)

 (458)

(919)

Net cash inflow from operating activities

 13,197

 6,205

1,741

Purchases of investments and derivatives

 (258,862)

 (322,461)

(620,647)

Sales of investments and derivatives

 282,414

 378,263

707,608

Settlement of forward currency contracts

 184

 53

118

Net cash inflow from investing activities

 23,736

 55,855

87,079

Dividends paid

 (8,661)

 (8,770)

(10,680)

Repurchase and cancellation of the Company'sown shares

 (4,412)

 -

(4,602)

Repayment of bank loans

 (42,528)

 -

-

Net cash outflow from financing activities

 (55,601)

 (8,770)

(15,282)

(Decrease)/increase in cash and cash equivalents

 (18,668)

 53,290

73,538

Cash and cash equivalents at start of period

 75,318

 1,407

1,407

Exchange movements

 1,079

 221

373

Cash and cash equivalents at end of period

 57,729

 54,918

75,318

(Decrease)/increase in cash and cash equivalents

 (18,668)

 53,290

73,538

Cash and cash equivalents consist of:

Cash and short term deposits

 266

 267

430

Cash held in JPMorgan Euro Liquidity Fund

 57,463

 54,651

74,888

Total

 57,729

 54,918

75,318

 

 

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED 30th SEPTEMBER 2022

1. Financial statements

The information contained within the financial statements in this half year report has not been audited or reviewed by the Company's auditors.

The figures and financial information for the year ended 31st March 2022 are extracted from the latest published financial statements of the Company and do not constitute statutory accounts for that year. Those financial statements have been delivered to the Registrar of Companies, including the report of the auditors which was unqualified and did not contain a statement under either section 498(2) or 498(3) of the Companies Act 2006.

2. Accounting policies

The financial statements have been prepared in accordance with the Companies Act 2006, FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' of the United Kingdom Generally Accepted Accounting Practice ('UK GAAP') and with the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' (the revised 'SORP') issued by the Association of Investment Companies in April 2021.

FRS 104, 'Interim Financial Reporting', issued by the Financial Reporting Council ('FRC') in March 2015has been applied in preparing this condensed set of financial statements for the six months ended30th September 2022.

All of the Company's operations are of a continuing nature.

The accounting policies applied to this condensed set of financial statements are consistent with those applied in the financial statements for the year ended 31st March 2022.

3. Return/(loss) per share

 

(Unaudited)

Six months ended 30th September 2022£'000

(Unaudited)

Six months ended

30th September 2021£'000

(Audited)

Year ended

31st March 2022

£'000

Return per share is based on the following:

Revenue return

 16,442

 10,471

11,154

Capital (loss)/return

 (167,043)

 101,654

(8,299)

Total (loss)/return

 (150,601)

 112,125

2,855

Weighted average number of sharesin issue

 157,662,663

 159,462,885

159,257,259

Revenue return per share

 10.43p

 6.57p

7.00p

Capital (loss)/return per share

 (105.95)p

 63.75p

(5.21)p

Total (loss)/return per share

 (95.52)p

 70.32p

1.79p

 

 

4. Dividends paid

 

(Unaudited)

Six months ended 30th September 2022£'000

(Unaudited)

Six months ended

30th September 2021£'000

(Audited)

Year ended

31st March 2022

£'000

2022 final dividend of 5.5p (2021: 5.5p) per share

 8,661

8,770

8,770

2022 interim dividend of 1.2p per share

-

-

1,910

Total dividends paid in the period/year

 8,661

8,770

10,680

 

All dividends paid in the period have been funded from the revenue reserve. For the year ended 31st March 2022 the dividend payment was split between revenue reserve and capital reserve as the revenue reserve opening balance was entirely exhausted.

An interim dividend of 1.2p (2021:1.2p) has been declared in respect of the six months ended 30th September 2022, amounting to £1,890,000.

5. Net asset value per share

 

(Unaudited)

Six months ended 30th September 2022

(Unaudited)

Six months ended

30th September 2021

(Audited)

Year ended

31st March 2022

Net assets (£'000)

 670,203

 949,659

833,719

Number of shares in issue

 157,474,931

 159,462,885

158,469,931

Net asset value per share

 425.6p

 595.5p

526.1p

6. Reconciliation of net (loss)/return before finance costs and taxation to net cash outflow from operations before dividends and interest

(Unaudited)

Six months ended 30th September 2022£'000

(Unaudited)

Six months ended

30th September 2021£'000

(Audited)

Year ended

31st March 2022

£'000

Net (loss)/return before finance costs and taxation

 (148,594)

 114,295

5,753

Add capital losses/(less capital return) before finance costs and taxation

 166,722

 (101,972)

7,666

Scrip dividends received as income

 (188)

-

-

(Increase)/decrease in accrued income and other debtors

 (1)

 14

(202)

(Decrease)/increase in accrued expenses

 (15)

 (25)

(1)

Management fee allocated to capital

 (2,308)

 (2,725)

(5,507)

Overseas withholding tax

 (3,093)

 (2,447)

(3,049)

Dividends received

 (16,084)

 (11,254)

(13,119)

Interest received

-

 (1)

(1)

Realised losses on foreign exchange transactions

 (59)

 (425)

(804)

Realised exchange gains/(losses) on liquidity

 738

 (200)

(1,413)

Net cash outflow from operations beforedividends and interest

 (2,882)

 (4,740)

(10,675)

 

 

7. Fair valuation of investments

The fair value hierarchy analysis for financial instruments held at fair value at the period end is as follows:

(Unaudited)

Six months ended

30th September 2022

(Unaudited)

Six months ended

30th September 2021

(Audited)

Year ended

31st March 2022

Assets

£'000

Liabilities

£'000

Assets

£'000

Liabilities £'000

Assets

£'000

Liabilities £'000

Level 1

 642,346

-

 961,055

-

834,018

-

Level 21

-

-

 1

 (18)

2

-

Total

 642,346

-

 961,056

 (18)

834,020

-

1 Includes forward foreign currency contracts.

 

 

 

13th December 2022

 

For further information, please contact:

 

Priyanka Vijay Anand

For and on behalf of JPMorgan Funds Limited,

Company Secretary

020 7742 4000

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

JPMORGAN ASSET MANAGEMENT (UK) LIMITED

ENDS

A copy of the half year report will be submitted to the FCA's National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

The half year will also shortly be available on the Company's website at www.jpmeuropeandiscovery.co.uk where up to date information on the Company, including daily NAV and share prices, factsheets and portfolio information can also be found.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR GRBDDLUBDGDX
Date   Source Headline
31st May 202411:04 amRNSNet Asset Value(s)
30th May 20245:08 pmRNSTransaction in Own Shares
30th May 202410:24 amRNSNet Asset Value(s)
29th May 20245:07 pmRNSTransaction in Own Shares
29th May 202410:34 amRNSNet Asset Value(s)
28th May 20244:19 pmRNSHolding(s) in Company
28th May 202411:41 amRNSGearing Announcement
28th May 202411:08 amRNSNet Asset Value(s)
24th May 20245:08 pmRNSTransaction in Own Shares
24th May 202410:37 amRNSNet Asset Value(s)
23rd May 202410:36 amRNSNet Asset Value(s)
22nd May 20245:12 pmRNSTransaction in Own Shares
22nd May 202411:08 amRNSNet Asset Value(s)
21st May 202411:39 amRNSNet Asset Value(s)
20th May 202411:56 amRNSGearing Announcement
20th May 202410:45 amRNSNet Asset Value(s)
17th May 202410:40 amRNSNet Asset Value(s)
16th May 20245:12 pmRNSTransaction in Own Shares
16th May 202410:37 amRNSNet Asset Value(s)
15th May 20245:03 pmRNSTransaction in Own Shares
15th May 202410:25 amRNSNet Asset Value(s)
14th May 202410:52 amRNSNet Asset Value(s)
13th May 202411:22 amRNSGearing announcement
13th May 202410:53 amRNSNet Asset Value(s)
13th May 20249:52 amRNSTen Largest Investments
10th May 20245:17 pmRNSTransaction in Own Shares
10th May 202410:59 amRNSNet Asset Value(s)
9th May 20245:03 pmRNSTransaction in Own Shares
9th May 202410:34 amRNSNet Asset Value(s)
8th May 20245:01 pmRNSTransaction in Own Shares
8th May 202410:24 amRNSNet Asset Value(s)
7th May 202411:47 amRNSGearing announcement
7th May 202411:09 amRNSNet Asset Value(s)
3rd May 20245:07 pmRNSTransaction in Own Shares
3rd May 202410:57 amRNSNet Asset Value(s)
2nd May 20245:04 pmRNSTransaction in Own Shares
2nd May 202411:19 amRNSNet Asset Value(s)
1st May 202412:05 pmRNSTotal Voting Rights
1st May 202411:23 amRNSNet Asset Value(s)
30th Apr 20245:06 pmRNSTransaction in Own Shares
30th Apr 202411:06 amRNSNet Asset Value(s)
29th Apr 20245:03 pmRNSTransaction in Own Shares
29th Apr 202412:01 pmRNSGearing Announcement
29th Apr 202411:05 amRNSNet Asset Value(s)
26th Apr 20244:59 pmRNSTransaction in Own Shares
26th Apr 202410:47 amRNSNet Asset Value(s)
25th Apr 20245:03 pmRNSTransaction in Own Shares
25th Apr 202410:10 amRNSNet Asset Value(s)
24th Apr 20245:18 pmRNSTransaction in Own Shares
24th Apr 202410:19 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.